Document is current
Any future updates will be listed below
-
Authors
Sibiude, J.
Winer, N.
Morel, O.
Lecarpentier, E.
Masson, D.
Perrotin, F.
Huissoud, C.
Kayem, G.
Piver, E.
Rota, M.
Bondon, J. P.
Buth, V.
Masson, G.
Guibourdenche, J.
Tsatsaris, V.
-
Funding
Funding for this research was provided by:
Funding was obtained from Roche Diagnostics for the study and biological tests
Funding from Roche Diagnostics for the study and biological tests
- License Information
-
More Information
Article History
Received: 21 October 2024
Accepted: 3 October 2025
First Online: 10 November 2025
Declarations
:
: All authors were independent of the funders. Disclosures V. Tsatsaris is a member of the advisory board and received speaker fees from Roche Diagnostics, Alexion and Sanofi. NW, OM, CH, FP, EP declare participation as expert and speaker activities for Roche Diagnostics France. JG received fees as expert in biochemical endocrinology to advisory boards from Merck. JS, EL, DM, GK, MR, FPB, VB and GM declare no conflict of interest.
